0.14 USD
▲-0.00+4.08%
2026-08-03
市值
$2.23M
市盈率
—
EPS
-1.43
股息率
—
52 周区间
0.10 – 1.40
成交量
502.97K
Beta
-1.20
目标价
0.78
52W 低 0.1052W 高 1.40
价格走势
公司简介
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, which is in a Ph...